Cell Based Assays Market Is Expanding at a CAGR of 7.7% During the Forecast Period of 2017 to 2022
A fresh study by Transparency Market Research (TMR) has observed that the global cell based assays market is divided among a large number of players, and the fragmented scenario will sustain in the near future too as more and more pharmaceutical and biotechnology companies make a foray in this developing market with their financial might. Having said that, a few companies do hold stronger position than the rest in the global cell based assays market, such as GE Healthcare Inc.,...
View full press release